Q9Y3Z3 (SAMH1_HUMAN) Homo sapiens (Human)

Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 UniProtKBInterProSTRINGInteractive Modelling

626 aa; Sequence (Fasta) ; (Isoform 3; Isoform 4; )

Sequence Features

Add
 233
 167Zinc; via tele nitrogen
 206Zinc; via tele nitrogen
 207Zinc
 311Zinc
 123H -> P (in AGS5; loss of oligomerization; decreased ability to restrict LINE-1 retrotransposon activity; dbSNP:rs121434520) VAR_058481 dbSNP
 143R -> C (in AGS5; loss of oligomerization; dbSNP:rs387906948) VAR_058482 dbSNP
 143R -> H (in AGS5; loss of oligomerization; decreased ability to restrict LINE-1 retrotransposon activity; dbSNP:rs369035155) VAR_058483 dbSNP
 145R -> Q (in AGS5; loss of oligomerization; decreased ability to restrict LINE-1 retrotransposon activity; dbSNP:rs515726145) VAR_058484 dbSNP
 167H -> Y (in AGS5; loss of function in defense response to virus; loss of oligomerization; decreased ability to restrict LINE-1 retrotransposon activity) VAR_070633
 201I -> N (in AGS5 and CHBL2; loss of function in defense response to virus; decreased oligomerization; decreased ability to restrict LINE-1 retrotransposon activity; dbSNP:rs138603088) VAR_058485 dbSNP
 209G -> S (in AGS5; does not affect oligomerization; decreased ability to restrict LINE-1 retrotransposon activity; does not affect localization to nucleus; dbSNP:rs121434516) VAR_058486 dbSNP
 254M -> V (in AGS5; loss of function in defense response to virus; does not affect oligomerization; decreased ability to restrict LINE-1 retrotransposon activity; dbSNP:rs121434521) VAR_058487 dbSNP
 290R -> H (in AGS5; loss of oligomerization; decreased ability to restrict LINE-1 retrotransposon activity; dbSNP:rs559553527) VAR_070634 dbSNP
 369L -> S (in AGS5; loss of function in defense response to virus; decreased oligomerization; dbSNP:rs515726139) VAR_058488 dbSNP
 385M -> V (in AGS5; loss of function in defense response to virus; loss of oligomerization; dbSNP:rs515726140) VAR_058489 dbSNP
 448I -> T (in AGS5; loss of function in defense response to virus; decreased oligomerization; does not affect localization to nucleus; novel localization to the cytoplasm; dbSNP:rs774964432) VAR_078240 dbSNP
 137-145GTP
 352-354dNTP
 120-123Missing (in AGS5) VAR_078239
 548-626Missing (in AGS5; Does not affect dNTP regulation, while affecting ability to promote DNA end resection at stalled replication forks) VAR_080530
 42-107Sterile alpha motif domain
IPR001660PF07647
 164-319HD domain
IPR006674PF01966

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
SAMHD1 Bound to Clofarabine-TP in the Catalytic Pocket and Allosteric Pocket Heteromer
8×HDV; 4×GTP; 10×MG; 23×NA; 7×GLY; 2×SIN; 1×PO4; 1×TCE;6dwd113-599
Assess
SAMHD1 Bound to Gemcitabine-TP in the Catalytic Pocket Heteromer
4×GTF; 4×GTP; 4×DTP; 10×MG; 4×NA; 1×NI;6dw5113-599
Assess
Crystal structure of human SAMHD1 (amino acid residues 582-626) bound to Vpx isolated from sooty ma… Heteromer
P19508; Q9Y4B6; 		2×PG4; 1×ZN;4cc9606-624
Assess
Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate…homo-4-mer 4×ZN; 10×DGT; 4×MG; 2×DTP;4mz7109-599
Assess
The structure of GTP-dATP-bound SAMHD1homo-4-mer 8×DTP; 4×GTP; 4×MG;4rxp109-599
Assess
The structure of GTP-dUTP-bound SAMHD1homo-4-mer 4×GTP; 8×DUT; 4×MG;4rxq109-599
Assess
The structure of GTP-dCTP-bound SAMHD1homo-4-mer 8×DCP; 4×MG; 4×GTP;4rxr109-599
Assess
The structure of GTP-dTTP-bound SAMHD1homo-4-mer 4×GTP; 8×TTP; 4×MG;4rxs109-599
Assess
Crystal structure of tetrameric human wt-SAMHD1 (residues 109-626) with GTP, dATP, dCMPNPP and Mghomo-4-mer 4×FE; 12×MG; 4×0KX; 4×GTP; 4×SO4; 4×DTP;6txc112-599
Assess
Crystal structure of the tetrameric dGTP-bound SAMHD1 mutant catalytic corehomo-4-mer 12×DGT; 8×MG;4bzb113-599
Assess
SAMHD1 Bound to Cladribine-TP in the Catalytic Pocket and Allosteric Pockethomo-4-mer 8×HF7; 4×GTP; 8×MG; 1×NA;6dw4113-599
Assess
Structural basis of cellular dNTP regulation, SAMHD1-GTP-dCTP-cCTP complexhomo-4-mer 8×DCP; 4×GTP; 4×MG;4tnp113-599
Assess
Crystal structure of the tetrameric GTP/dATP/ATP-bound SAMHD1 (H210A) mutant catalytic corehomo-4-mer 4×GTP; 4×DTP; 4×MG; 4×ZN;4qg4113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-GTP-dGTP-dCTP complexhomo-4-mer 4×DCP; 8×MG; 4×GTP; 4×DGT;4to4113-599
Assess
Crystal structure of the tetrameric dGTP/dCTP-bound SAMHD1 (RN206) mutant catalytic corehomo-4-mer 8×DGT; 4×DCP; 8×MG;4qfy113-599
Assess
SAMHD1 HD domain bound to decitabine triphosphatehomo-4-mer 8×F6G; 4×GTP; 4×MG;6cm2113-599
Assess
Structural basis of cellular dNTP regulation, SAMHD1-dGTP-dGTP-dCTP complexhomo-4-mer 4×DCP; 8×MG; 8×DGT;4to3113-599
Assess
SAMHD1 Bound to Cytarabine-TP in the Catalytic Pockethomo-4-mer 4×HF4; 4×DTP; 8×MG; 4×GTP;6dw3113-599
Assess
Crystal structure of the tetrameric dGTP/dATP-bound SAMHD1 (RN206) mutant catalytic corehomo-4-mer 8×DGT; 4×DTP; 8×MG;4qfx113-599
Assess
Crystal structure of the tetrameric GTP/dATP-bound SAMHD1 (RN206) mutant catalytic corehomo-4-mer 8×DTP; 4×MG; 4×GTP;4qg1113-599
Assess
Crystal structure of tetrameric human H215A-SAMHD1 (residues 109-626) with GTP, dAMPNPP and Mghomo-4-mer 4×FE; 13×MG; 8×DZ4; 4×GTP;6xu1113-599
Assess
Crystal structure of the tetrameric GTP/dATP/ATP-bound SAMHD1 (RN206) mutant catalytic corehomo-4-mer 4×GTP; 4×DTP; 4×MG;4qg2113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-dGTP-dGTP-dGTP/dTTP complexhomo-4-mer 11×DGT; 8×MG; 1×TTP;4to2113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP-dCTP complexhomo-4-mer 4×DCP; 4×GTP; 4×DTP; 4×MG;4to0113-599
Assess
Crystal structure of the tetrameric dGTP/dUTP-bound SAMHD1 (RN206) mutant catalytic corehomo-4-mer 4×DGT; 8×DUT; 7×MG; 1×EDO;4qg0113-599
Assess
Crystal structure of the tetrameric dGTP/dTTP-bound SAMHD1 (RN206) mutant catalytic corehomo-4-mer 4×DGT; 8×TTP; 9×MG;4qfz113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-GTP-dGTP complexhomo-4-mer 4×DGT; 4×GTP; 4×MG; 1×3PO;4tnx113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP-dTTP complexhomo-4-mer 4×TTP; 8×MG; 4×GTP; 4×DTP;4tnz113-599
Assess
SAMHD1 Bound to Vidarabine-TP in the Catalytic Pockethomo-4-mer 4×HEJ; 4×GTP; 4×DTP; 10×MG; 17×NA; 1×GLY; 1×PO4;6dwj113-599
Assess
SAMHD1 without Catalytic Nucleotideshomo-4-mer 4×DTP; 4×MG; 4×GTP; 2×GLY; 3×NA; 1×PO4;6dw7113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP/dCTP-dCTP complexhomo-4-mer 6×DCP; 2×DTP; 4×MG; 4×GTP;4to1113-599
Assess
Structural basis of cellular dNTP regulation, SAMHD1-GTP-dTTP-dTTP complexhomo-4-mer 8×TTP; 4×GTP; 4×MG;4tnq113-599
Assess
Structural basis of cellular dNTP regulation, SAMHD1-dGTP-dATP-dGTP complexhomo-4-mer 8×DGT; 4×DTP; 4×MG;4tny113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP-dATP complexhomo-4-mer 7×DTP; 4×GTP; 4×MG;4tnr113-599
Assess
Structure basis of cellular dNTP regulation, SAMHD1-GTP-dTTP-dCTP complexhomo-4-mer 4×DCP; 4×GTP; 4×TTP; 4×MG;4to5113-599
Assess
Crystal structure of the tetrameric dGTP-bound wild type SAMHD1 catalytic corehomo-4-mer 12×T8T; 4×MN; 4×MG;4bzc113-599
Assess
Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dAMPNPP and Mghomo-4-mer 4×FE; 12×MG; 8×DZ4; 4×CZF;6tx0114-599
Assess
Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dAMPNPP and Mnhomo-4-mer 4×FE; 12×MN; 8×DZ4; 4×CZF;6txf114-599
Assess
SAMHD1 Bound to Fludarabine-TP in the Catalytic Pockethomo-4-mer 4×HFD; 4×GTP; 4×DTP; 9×MG; 23×NA; 12×GLY; 2×TRS; 1×PO4;6dwk113-598
Assess
Structure basis of cellular dNTP regulation, SAMHD1-dGTP-dATP-dTTP/dGTP complexhomo-4-mer 3×TTP; 5×DGT; 4×DTP; 4×MG;4to6114-599
Assess
Crystal structure of the dGTP-bound catalytic core of SAMHD1 T592V mutanthomo-4-mer 12×DGT; 5×MG;4zwe114-599
Assess
Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dGMPNPP and Mghomo-4-mer 4×FE; 12×MG; 8×XG4; 4×CZF; 4×SO4;6txa114-599
Assess
Crystal structure of tetrameric human wt-SAMHD1 (residues 109-626) with GTP, dATP, dTMPNPP and Mghomo-4-mer 4×FE; 8×MG; 4×1FZ; 4×GTP; 4×DTP; 3×SO4;6txe114-599
Assess
Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dATP, dCMPNPP, Mn a…homo-4-mer 4×FE; 4×MN; 8×MG; 4×0KX; 4×CZF; 4×DTP;6yom114-598
Assess
Crystal structure of the GTP-dATP-bound catalytic core of SAMHD1 phosphomimetic T592E mutanthomo-4-mer 8×DTP; 4×GTP; 4×MG;4zwg113-589
Assess
Crystal structure of human SAMHD1 (amino acid residues 41-583) bound to ddGTPhomo-4-mer 4×FE; 8×DG3; 4×MG;5ao0110-583
Assess
Crystal structure of human SAMHD1 (amino acid residues 115-583) bound to ddGTPhomo-4-mer 4×FE; 8×DG3; 4×SO4; 4×MG;5ao1115-583
Assess
Crystal structure of human SAMHD1 (amino acid residues 115-626) bound to GTPhomo-4-mer 4×FE; 4×GTP; 11×SO4;5ao3115-583
Assess
Crystal structure of in vitro phosphorylated human SAMHD1 (amino acid residues 115-626) bound to GTPhomo-4-mer 4×FE; 4×GTP;5ao4115-583
Assess
Crystal structure of human SAMHD1 (amino acid residues 115-583) R164A variant bound to dGTPhomo-4-mer 4×FE; 4×DGT;5ao2115-582
Assess
Human SAMHD1 bound to deoxyribo(C*G*C*C*T)-oligonucleotidehomo-2-mer 2×ZN;6u6x114-583
Assess
Crystal structure of SAMHD1 catalytic core with GTPhomo-2-mer 2×ZN; 2×GTP;4q7h115-584
Assess
The structure of GTP-bound SAMHD1homo-2-mer 2×ZN; 2×PO4; 2×GTP;4rxo114-583
Assess
Human SAMHD1 bound to ribo(CGCCU)-oligonucleotidehomo-2-mer 2×ZN; 2×DTP;6u6y115-583
Assess
Human SAMHD1 bound to deoxyribo(TG*TTCA)-oligonucleotidehomo-2-mer 2×ZN;6u6z116-583
Assess
Structure of the catalytic core of human SAMHD1homo-2-mer 2×PO4; 2×ZN;3u1n120-583
Assess
Solution structure of the N-terminal SAM-domain of the SAM domain and HD domain containing protein …monomer 2e8o23-118
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
monomer -1.62 6brh.1.A40-582
74.551×MG;
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 3homo-4-mer4×GTP;-0.074rxq.1.C111-529
97.31
Assess
Isoform 3monomer-1.896brh.1.A40-512
71.56
Assess
Isoform 3homo-4-mer2×MG;-3.074rxq.1.C109-529
79.63
Assess
Isoform 4monomer1×DUT;-0.614rxq.1.B109-564
99.79
Assess
Isoform 4monomer1×MG;-0.936brh.1.A40-547
75.26
Assess